AgPlus Electrochemical COVID-19 Diagnostic Assay

SARS-CoV-2或新冠肺炎目前正在世界各地传播。人们对这种病毒知之甚少，但我们学得很快，很明显，我们需要良好、准确的诊断来支持隔离和治疗。已知的是，病毒的连续间隔为4天，1-3%的人口可能出现症状前症状，但仍在传播病毒。感染后需要2-14天才能出现症状，97%的人在11.5天内出现症状。这是在我们的医疗保健系统不堪重负之前阻止疾病传播的全球性挑战。AgPlus用于检测对新冠肺炎病毒的特定免疫反应的诊断试验将允许a)对有症状的人进行确认性测试(排除在外)，了解在某些情况下这些症状可能是由细菌感染引起的b)监测那些检测呈阳性的人的治疗效果，以确保他们对此有反应，何时可以安全地从隔离中释放c)可能成为辅助诊断方法，以支持药物/疫苗开发d)测试以确认患者是否以前感染过新冠肺炎\。

SARS-CoV-2 or COVID-19 is currently spreading throughout the world. Little is understood about the virus but we are learning fast and it is clear that we need to have good, accurate diagnosis to support quarantine and treatment.What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic but still transmitting the virus. It takes 2-14 days to show symptoms after infection with the 97% of people developing symptoms within 11.5 days. This is a global challenge to halt the spread of the disease before our healthcare systems become overwhelmed.AgPlus' diagnostic assay for detecting specific immune responses to the COVID-19 virus will allow for a) confirmatory testing (rule in rule out) of those with symptoms, understanding that in some instances the symptoms may be due to bacterial infection b) monitoring treatment efficacy in those that have tested positive to ensure they are responding and when safe to release from isolation c) potential to be a companion diagnostic to support drug/ vaccine development d) test to confirm if patient has previously been infected with COVID-19\.